Pfizer's Turnaround Has Truly Started (Earnings Update)

Since my last analysis of Pfizer , advocating that the company could be a strong turnaround contender, and I believe that following the strong earnings beat, Pfizer is certainly on track to turn things around.As a detail-oriented investor with a strong foundation in finance and business writing, I focus on analyzing undervalued and disliked companies or industries that have strong fundamentals and good cash flows. I have a particular interest in sectors such as Oil&Gas and consumer goods. Basically, anythin ...